Evidence Summary
Evidence Level: Preliminary
Mechanism: Enrollment: Estimated, Sponsor Type: Other, Unknown / General
Safety: Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing: See linked studies/trials for reported doses and durations; typical protocols vary widely.
Plasma levels inversely correlated with PASC severity. 1-3g/day raises levels. Mitochondrial + NF-kB rationale. Safe; may help energy/autonomic symptoms. Good mechanistic support, limited direct trials.